XTRA:FMEHealthcare
Assessing Fresenius Medical Care (XTRA:FME) Valuation After Upbeat 2025 Growth And Earnings Guidance
Why Fresenius Medical Care Stock Is Back in Focus
Fresenius Medical Care (XTRA:FME) has grabbed investor attention after confirming it expects to hit the top end of its 2025 revenue growth range and projecting high-teens to high-20s operating income growth.
See our latest analysis for Fresenius Medical Care.
Despite the upbeat 2025 guidance and progress in home hemodialysis, Fresenius Medical Care’s recent trading has been choppy. The 1 day share price return was 1.46% to €37.47 after a sharp...